X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ELDER PHARMA FDC LTD./
ELDER PHARMA
 
P/E (TTM) x 29.1 -0.2 - View Chart
P/BV x 6.1 0.1 6,002.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 FDC LTD.   ELDER PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ELDER PHARMA
Jun-14
FDC LTD./
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs144380 37.8%   
Low Rs79188 42.0%   
Sales per share (Unadj.) Rs47.6491.2 9.7%  
Earnings per share (Unadj.) Rs7.6-3.2 -239.2%  
Cash flow per share (Unadj.) Rs9.014.4 62.5%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5376.5 12.6%  
Shares outstanding (eoy) m177.8320.54 865.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.6 404.5%   
Avg P/E ratio x14.6-89.3 -16.4%  
P/CF ratio (eoy) x12.319.7 62.6%  
Price / Book Value ratio x2.30.8 310.3%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7845,833 339.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2212,179 56.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45910,089 83.8%  
Other income Rs m394257 153.4%   
Total revenues Rs m8,85210,346 85.6%   
Gross profit Rs m2,070-792 -261.4%  
Depreciation Rs m249361 68.9%   
Interest Rs m312,756 1.1%   
Profit before tax Rs m2,184-3,653 -59.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m606125 483.9%   
Profit after tax Rs m1,353-65 -2,070.6%  
Gross profit margin %24.5-7.8 -311.8%  
Effective tax rate %27.7-3.4 -809.4%   
Net profit margin %16.0-0.6 -2,469.8%  
BALANCE SHEET DATA
Current assets Rs m4,3559,240 47.1%   
Current liabilities Rs m1,7929,998 17.9%   
Net working cap to sales %30.3-7.5 -403.5%  
Current ratio x2.40.9 263.0%  
Inventory Days Days4446 96.0%  
Debtors Days Days2560 41.2%  
Net fixed assets Rs m3,02510,124 29.9%   
Share capital Rs m179206 86.8%   
"Free" reserves Rs m8,2435,582 147.7%   
Net worth Rs m8,4537,734 109.3%   
Long term debt Rs m114,889 0.2%   
Total assets Rs m10,55722,882 46.1%  
Interest coverage x71.4-0.3 -21,954.5%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.80.4 181.7%   
Return on assets %13.111.8 111.5%  
Return on equity %16.0-0.8 -1,894.4%  
Return on capital %23.522.3 105.4%  
Exports to sales %13.33.0 437.9%   
Imports to sales %3.30.4 782.6%   
Exports (fob) Rs m1,126307 367.2%   
Imports (cif) Rs m28343 656.1%   
Fx inflow Rs m1,146307 373.8%   
Fx outflow Rs m355125 283.6%   
Net fx Rs m791181 436.2%   
CASH FLOW
From Operations Rs m1,48511,754 12.6%  
From Investments Rs m-620-561 110.5%  
From Financial Activity Rs m-753-6,762 11.1%  
Net Cashflow Rs m1134,432 2.5%  

Share Holding

Indian Promoters % 68.9 39.6 174.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.5 62.7%  
FIIs % 7.5 16.8 44.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 36.1 52.6%  
Shareholders   23,730 16,479 144.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  VENUS REMEDIES  

Compare FDC LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS